William Blair & Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-1,486
Closed -$273K 1985
2021
Q2
$273K Sell
1,486
-331
-18% -$60.8K ﹤0.01% 1377
2021
Q1
$278K Buy
1,817
+74
+4% +$11.3K ﹤0.01% 1359
2020
Q4
$272K Buy
+1,743
New +$272K ﹤0.01% 1312
2020
Q2
Sell
-3,450
Closed -$310K 1775
2020
Q1
$310K Buy
3,450
+746
+28% +$67K ﹤0.01% 1007
2019
Q4
$292K Buy
+2,704
New +$292K ﹤0.01% 1180
2018
Q4
Sell
-1,575
Closed -$219K 1801
2018
Q3
$219K Sell
1,575
-631
-29% -$87.7K ﹤0.01% 1257
2018
Q2
$274K Sell
2,206
-655
-23% -$81.4K ﹤0.01% 1161
2018
Q1
$319K Buy
2,861
+31
+1% +$3.46K ﹤0.01% 1051
2017
Q4
$338K Sell
2,830
-580
-17% -$69.3K ﹤0.01% 1090
2017
Q3
$478K Sell
3,410
-3,921
-53% -$550K ﹤0.01% 945
2017
Q2
$892K Sell
7,331
-1,439
-16% -$175K 0.01% 784
2017
Q1
$1.15M Buy
8,770
+235
+3% +$30.8K 0.01% 671
2016
Q4
$1.04M Sell
8,535
-7,365
-46% -$901K 0.01% 641
2016
Q3
$1.95M Buy
15,900
+2,069
+15% +$253K 0.02% 501
2016
Q2
$1.62M Buy
13,831
+5,678
+70% +$663K 0.02% 511
2016
Q1
$1.14M Sell
8,153
-10,560
-56% -$1.47M 0.01% 592
2015
Q4
$3.57M Buy
18,713
+11,409
+156% +$2.18M 0.03% 346
2015
Q3
$1.14M Sell
7,304
-8,009
-52% -$1.25M 0.01% 723
2015
Q2
$2.77M Buy
15,313
+12,989
+559% +$2.35M ﹤0.01% 1235
2015
Q1
$402K Sell
2,324
-185
-7% -$32K ﹤0.01% 1791
2014
Q4
$464K Buy
2,509
+184
+8% +$34K ﹤0.01% 1703
2014
Q3
$385K Buy
2,325
+205
+10% +$33.9K ﹤0.01% 1763
2014
Q2
$331K Sell
2,120
-1,368
-39% -$214K ﹤0.01% 1779
2014
Q1
$530K Buy
3,488
+903
+35% +$137K ﹤0.01% 1599
2013
Q4
$343K Buy
2,585
+7
+0.3% +$929 ﹤0.01% 1698
2013
Q3
$299K Sell
2,578
-10,598
-80% -$1.23M ﹤0.01% 1726
2013
Q2
$1.22M Buy
+13,176
New +$1.22M ﹤0.01% 1210